| |
original article |
Date |
Title |
Authors Max. 6 Authors |
| 1 |
[GO] |
2024―Apr―09 |
Antiphospholipid syndrome in the era of COVID-19 - Two sides of a coin |
Naim Mahroum, Mona Habra, Mohamad Aosama Alrifaai, Yehuda Shoenfeld |
| 2 |
[GO] |
2024―Mar―13 |
Clinical phenotype of AAV, anti-GBM disease and double-positive patients after SARS-CoV-2 vaccination |
Yisha Li, Jie Wang, Shuang Liang, Yan Zhang, Zhe Feng, Guangyan Cai |
| 3 |
[GO] |
2023―Dec―29 |
Autoimmune response after SARS-CoV-2 infection and SARS-CoV-2 vaccines |
Altijana Hromić-Jahjefendić, Kenneth Lundstrom, Muhamed Adilović, Alaa A.A. Aljabali, Murtaza M. Tambuwala, Ángel Serrano-Aroca, Vladimir N. Uversky |
| 4 |
[GO] |
2023―Aug―18 |
Increased incidence of rheumatoid arthritis after COVID-19 |
Juan Sebastian Marín, Enrique A. Mazenett-Granados, Juan Carlos Salazar-Uribe, Mauricio Sarmiento, John Fredy Suárez, Manuel Rojas, Marlon Munera, Rosalbina Pérez, Claudia Morales, Jorge I. Dominguez, Juan-Manuel Anaya |
| 5 |
[GO] |
2023―Jul―23 |
COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis |
Abolfazl Akbari, Alireza Hadizadeh, Muhammad Islampanah, Ensie Salavati Nik, Stephen L. Atkin, Amirhossein Sahebkar |
| 6 |
[GO] |
2023―Jul―15 |
Autoreactive T cells of ankylosing spondylitis elicited by COVID-19 infection: A snapshot of autoimmune imprinting and immunological host defense |
Ming Zheng |
| 7 |
[GO] |
2023―Apr―17 |
Insights into new-onset autoimmune diseases after COVID-19 vaccination |
Ming Guo, Xiaoxiao Liu, Xiangmei Chen, Qinggang Li |
| 8 |
[GO] |
2023―Apr―14 |
Increased incidence of giant cell arteritis and associated stroke during the COVID-19 pandemic in Spain: A nation-wide population study |
Víctor Moreno-Torres, Vicente Soriano, Jorge Calderón-Parra, María Martínez-Urbistondo, Ana Treviño, Zayrho de San Vicente, Carmen de Mendoza, Guillermo Ruiz-Irastorza |
| 9 |
[GO] |
2023―Feb―03 |
COVID-19 vaccine safety during pregnancy in women with systemic lupus erythematosus |
Nefeli Giannopoulou, Latika Gupta, Laura Andreoli, Daniele Lini, Elena Nikiphorou, Rohit Aggarwal, Vikas Agarwal, Ioannis Parodis |
| 10 |
[GO] |
2023―Feb―02 |
COVID-19 and autoimmune bullous diseases: Lessons learned |
Michael Kasperkiewicz, David T. Woodley |
| 11 |
[GO] |
2023―Feb―02 |
Antinuclear antibodies in individuals with COVID-19 reflect underlying disease: Identification of new autoantibodies in systemic sclerosis (CDK9) and malignancy (RNF20, RCC1, TRIP13) |
Xavier Bossuyt, Jean-Baptiste Vulsteke, Jan Van Elslande, Lise Boon, Greet Wuyts, Silke Willebrords, Glynis Frans, Nick Geukens, Sebastien Carpentier, Sabine Tejpar, Hans Wildiers, Daniel Blockmans, Ellen De Langhe, Pieter Vermeersch, Rita Derua |
| 12 |
[GO] |
2022―Nov―19 |
Complement activation predicts negative outcomes in COVID-19: The experience from Northen Italian patients. |
Pier Luigi Meroni, Stefania Croci, Paola Adele Lonati, Francesca Pregnolato, Lucia Spaggiari, Giulia Besutti, Martina Bonacini, Ilaria Ferrigno, Alessandro Rossi, Geir Hetland, Ivana Hollan, Massimo Cugno, Francesco Tedesco, Maria Orietta Borghi, Carlo Salvarani |
| 13 |
[GO] |
2022―Oct―03 |
COVID-19 and the antiphospholipid syndrome |
Manuel Serrano, Gerard Espinosa, Antonio Serrano, Ricard Cervera |
| 14 |
[GO] |
2022―Aug―23 |
Thyroid autoimmunity and SARS-CoV-2 infection: Report of a large Italian series |
Poupak Fallahi, Silvia Martina Ferrari, Giusy Elia, Sabrina Rosaria Paparo, Armando Patrizio, Eugenia Balestri, Valeria Mazzi, Laura Gragnani, Clodoveo Ferri, Chiara Botrini, Francesca Ragusa, Alessandro Antonelli |
| 15 |
[GO] |
2022―Apr―09 |
Worsening of Graves' ophthalmopathy after SARS-CoV-2 mRNA vaccination |
Armando Patrizio, Silvia Martina Ferrari, Alessandro Antonelli, Poupak Fallahi |
| 16 |
[GO] |
2021―Dec―16 |
The impact of the COVID-19 pandemic on the global assessments of rheumatology clinimetrics: Data from a mobile application. A comment on article by Nagy E, et al.: “The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned” |
Nejc Tomšič, Matija Tomšič, Žiga Rotar, Alojzija Hočevar, Victor Savevski, Carlo F. Selmi |
| 17 |
[GO] |
2021―Dec―09 |
Autoantibodies and infection with SARS-CoV2 infection: The spectrum from association to clinical implication report of the 15th Dresden symposium on autoantibodies |
Jan Damoiseaux, Arad Dotan, Marvin J. Fritzler, Dimitrios P. Bogdanos, Pier Luigi Meroni, Dirk Roggenbuck, Michel Goldman, Nils Landegren, Paul Bastard, Yehuda Shoenfeld, Karsten Conrad |
| 18 |
[GO] |
2021―Nov―16 |
Could oxytocin reduce autoimmune disease in COVID-19? |
Phuoc-Tan Diep, Véronique de Kok |
| 19 |
[GO] |
2021―Nov―02 |
Immune mediated events timely associated with COVID-19 vaccine. A comment on article by Badier, et al.: “IgA vasculitis in adult patients following vaccination by ChadOx1 nCoV-19” |
Alojzija Hočevar, Matija Tomšič |
| 20 |
[GO] |
2021―Oct―28 |
The COVID-19 pandemic and ANCA-associated vasculitis - reports from the EUVAS meeting and EUVAS education forum |
Andreas Kronbichler, Duvuru Geetha, Rona M. Smith, Allyson C. Egan, Ingeborg M. Bajema, Ulf Schönermarck, Alfred Mahr, Hans-Joachim Anders, Annette Bruchfeld, Maria C. Cid, David R.W. Jayne |
| 21 |
[GO] |
2021―Oct―28 |
The impact of the COVID-19 pandemic on autoimmune diagnostics in Europe: A lesson to be learned |
Eszter Nagy, Maria Infantino, Nicola Bizzaro, Hristina Andreeva, Hetty J. Bontkes, Xavier Bossuyt, Nicole Fabien, Katarzyna Fischer, Ingmar A.F.M. Heijnen, Manfred Herold, Ana Kozmar, Liisa Kuhi, Marcos López-Hoyos, Rille Pullerits, Maria José Rego Sousa, Alexandra Tsirogianni, Jan Damoiseaux |
| 22 |
[GO] |
2021―Sep―10 |
The immune-neuroendocrine system in COVID-19, advanced age and rheumatic diseases |
Luis J. Jara, Berenice López-Zamora, Irvin Ordoñez-González, María F. Galaviz-Sánchez, Caroline I. Gutiérrez-Melgarejo, Miguel A. Saavedra, Olga L. Vera-Lastra, María Pilar Cruz-Domínguez, Gabriela Medina |
| 23 |
[GO] |
2021―Sep―09 |
Autoimmunity roots of the thrombotic events after COVID-19 vaccination |
Fatma Elrashdy, Murtaza M. Tambuwala, Sk. Sarif Hassan, Parise Adadi, Murat Seyran, Tarek Mohamed Abd El-Aziz, Nima Rezaei, Amos Lal, Alaa A.A. Aljabali, Ramesh Kandimalla, Nicolas G. Bazan, Gajendra Kumar Azad, Samendra P. Sherchan, Pabitra Pal Choudhury, Ángel Serrano-Aroca, Kazuo Takayama, Gaurav Chauhan, Damiano Pizzol, Debmalya Barh, Pritam Kumar Panda, Yogendra K. Mishra, Giorgio Palé, Kenneth Lundstrom, Elrashdy M. Redwan, Vladimir N. Uversky |
| 24 |
[GO] |
2021―Sep―09 |
IgA vasculitis in adult patient following vaccination by ChadOx1 nCoV-19 |
Laure Badier, Albanie Toledano, Tiphaine Porel, Sylvain Dumond, Julien Jouglen, Laurent Sailler, Haleh Bagheri, Guillaume Moulis, Margaux Lafaurie |
| 25 |
[GO] |
2021―Aug―30 |
Response to SARS-CoV-2 vaccination in immune mediated inflammatory diseases: Systematic review and meta-analysis |
Anuraag Jena, Shubhra Mishra, Parakkal Deepak, Praveen Kumar-M, Aman Sharma, Yusuf I. Patel, Nicholas A. Kennedy, Alfred H.J. Kim, Vishal Sharma, Shaji Sebastian |
| 26 |
[GO] |
2021―Jul―22 |
Antiphospholipid antibodies and COVID-19 |
Antonio La Cava |
| 27 |
[GO] |
2021―Jul―16 |
The mechanism behind flaring/triggering of autoimmunity disorders associated with COVID-19 |
Elrashdy M. Redwan, Mohammed F. Alghamdi, Tarek Mohamed Abd El-Aziz, Parise Adadi, Alaa A.A. Aljabali, Diksha Attrish, Gajendra Kumar Azad, Wagner Baetas-da-Cruz, Debmalya Barh, Nicolas G. Bazan, Adam M. Brufsky, Gaurav Chauhan, S.K. Sarif Hassan, Ramesh Kandimalla, Amos Lal, Kenneth Lundstrom, Yogendra Kumar Mishra, Pabitra Pal Choudhury, Giorgio Palé, Pritam K. Panda, Damiano Pizzol, Nima Rezaei, Ángel Serrano-Aroca, Samendra P. Sherchan, Murat Seyran, Kazuo Takayama, Murtaza M. Tambuwala, Bruce D. Uhal, Vladimir N. Uversky |
| 28 |
[GO] |
2021―Jul―15 |
Similarities between COVID-19 and systemic sclerosis early vasculopathy: A “viral” challenge for future research in scleroderma |
Marco Matucci Cerinic, Michael Hughes, Gloria Taliani, Bashar Kahaleh |
| 29 |
[GO] |
2021―Jul―03 |
COVID-19-related autoimmune disorders of central nervous system (CRAD-C): Is it a new entity? |
Abdorreza Naser Moghadasi |
| 30 |
[GO] |
2021―Jun―10 |
Autoimmunity and COVID-19 - The microbiotal connection |
Nurit Katz-Agranov, Gisele Zandman-Goddard |
| 31 |
[GO] |
2021―Jun―10 |
Guillain Barré syndrome associated with COVID-19- lessons learned about its pathogenesis during the first year of the pandemic, a systematic review |
Mayka Freire, Ariadna Andrade, Bernardo Sopeña, Maria Lopez-Rodriguez, Pablo Varela, Purificación Cacabelos, Helena Esteban, Arturo González-Quintela |
| 32 |
[GO] |
2021―May―08 |
Zipper method is the emerging treatment option for severe Guillain-Barre syndrome related COVID-19 |
Ozlem Saritas Nakip, Selman Kesici, Benan Bayrakci |
| 33 |
[GO] |
2021―Apr―19 |
Follow-up of COVID-19 patients: LA is transient but other aPLs are persistent |
Olivier Vollmer, Charles Tacquard, Yannick Dieudonné, Benoit Nespola, Laurent Sattler, Lélia Grunebaum, Vincent Gies, Mirjana Radosavljevic, Charlotte Kaeuffer, Yves Hansmann, Jean-Christophe Weber, Thierry Martin, Laurent Arnaud, Olivier Morel, Aurélien Guffroy, Olivier Collange, Paul Michel Mertes, Anne-Sophie Korganow, Xavier Delabranche, Vincent Poindron |
| 34 |
[GO] |
2021―Mar―18 |
A 31-year-old female patient with concurrent clinical onset of multiple sclerosis and COVID-19: Possible role of SARS-CoV-2 in the pathogenesis of multiple sclerosis |
Abdorreza Naser Moghadasi |
| 35 |
[GO] |
2021―Feb―21 |
Clinical outcomes of COVID-19 in patients with rheumatic diseases: A systematic review and meta-analysis of global data |
Chuanhui Xu, Zixi Yi, Ruyi Cai, Ru Chen, Bernard Yu-Hor Thong, Rong Mu |
| 36 |
[GO] |
2021―Feb―21 |
Molecular mimicry between SARS-CoV-2 and human proteins |
Yekbun Adiguzel |
| 37 |
[GO] |
2021―Feb―21 |
The SARS-CoV-2 as an instrumental trigger of autoimmunity |
Arad Dotan, Sylviane Muller, Darja Kanduc, Paula David, Gilad Halpert, Yehuda Shoenfeld |
| 38 |
[GO] |
2021―Jan―18 |
Association of COVID-19 and Acute Disseminated Encephalomyelitis (ADEM) in the absence of pulmonary involvement |
Shaghayegh Shahmirzaei, Abdorreza Naser Moghadasi |
| 39 |
[GO] |
2021―Jan―18 |
Autoantibodies in COVID-19: frequency and function |
Zhao-wei Gao, Hui-zhong Zhang, Chong Liu, Ke Dong |
| 40 |
[GO] |
2020―Dec―15 |
Combined Anakinra and Ruxolitinib treatment to rescue extremely ill COVID-19 patients: A pilot study. |
Gilles Kaplanski, Denis Bontemps, Pierre Esnault, Valery Blasco, Julien Carvelli, David Delarbre, Raphael Cauchois, Jean-Marie Forel, Laurent Papazian |
| 41 |
[GO] |
2020―Dec―13 |
Antiphospholipid antibodies and thrombotic events in COVID-19 patients hospitalized in medicine ward |
Alexandre Le Joncour, Corinne Frere, Isabelle Martin-Toutain, Paul Gougis, Pascale Ghillani-Dalbin, Georgina Maalouf, Matheus Vieira, Anne-Geneviève Marcelin, Joe-Elie Salem, Yves Allenbach, David Saadoun, Olivier Benveniste, Patrice Cacoub |
| 42 |
[GO] |
2020―Oct―28 |
SARS-CoV-2, the autoimmune virus |
Gilad Halpert, Yehuda Shoenfeld |
| 43 |
[GO] |
2020―Oct―27 |
COVID-19 and Immune-Mediated Inflammatory Diseases: Why don't our patients get worse? |
Víctor M. Martínez-Taboada, Marcos López-Hoyos, Javier Crespo, José L. Hernández |
| 44 |
[GO] |
2020―Oct―22 |
Guillian Barré syndrome and COVID-19: Possible role of the cytokine storm |
Faraz S. Hussain, Mohamed A. Eldeeb, Derrick Blackmore, Zaeem A. Siddiqi |
| 45 |
[GO] |
2020―Sep―14 |
Screening neuromyelitis optica patients for COVID-19 infection |
Omid Mirmosayyeb, Saeed Vaheb, Mahdi Barzegar, Vahid Shaygannejad, Simona Bonavita, Mahsa Ghajarzadeh |
| 46 |
[GO] |
2020―Sep―14 |
What can we learn from rapidly progressive interstitial lung disease related to anti-MDA5 dermatomyositis in the management of COVID-19? |
Enrico De Lorenzis, Gerlando Natalello, Laura Gigante, Lucrezia Verardi, Silvia Laura Bosello, Elisa Gremese |
| 47 |
[GO] |
2020―Aug―13 |
Risk of COVID-19 in celiac disease patients |
Fabiana Zingone, Anna D'Odorico, Greta Lorenzon, Ilaria Marsilio, Fabio Farinati, Edoardo Vincenzo Savarino |
| 48 |
[GO] |
2020―Jun―11 |
Molecular mimicry may explain multi-organ damage in COVID-19 |
Francesca Angileri, Sébastien Legare, Antonella Marino Gammazza, Everly Conway de Macario, Alberto JL Macario, Francesco Cappello |
| 49 |
[GO] |
2020―Jun―11 |
Covid-19 and autoimmunity |
Michael Ehrenfeld, Angela Tincani, Laura Andreoli, Marco Cattalini, Assaf Greenbaum, Darja Kanduc, Jaume Alijotas-Reig, Vsevolod Zinserling, Natalia Semenova, Howard Amital, Yehuda Shoenfeld |
| 50 |
[GO] |
2020―May―05 |
Novel COronaVirus Disease 2019 (COVID-19) epidemic: What are the risks for systemic sclerosis patients? |
Nicoletta Del Papa, Gianluca Sambataro, Antonina Minniti, Francesca Pignataro, Roberto Caporali |
| 51 |
[GO] |
2020―May―05 |
How to handle patients with autoimmune rheumatic and inflammatory bowel diseases in the COVID-19 era: An expert opinion |
Piercarlo Sarzi-Puttini, Daniela Marotto, Marco Antivalle, Fausto Salaffi, Fabiola Atzeni, Giovanni Maconi, Giovanni Monteleone, Giuliano Rizzardini, Spinello Antinori, Massimo Galli, Sandro Ardizzone |
| 52 |
[GO] |
2020―May―05 |
COVID-19 gone bad: A new character in the spectrum of the hyperferritinemic syndrome? |
Serena Colafrancesco, Cristiano Alessandri, Fabrizio Conti, Roberta Priori |
| 53 |
[GO] |
2020―May―05 |
Why judiciously timed anti-IL 6 therapy may be of benefit in severe COVID-19 infection |
Louise Cunningham, Ian Kimber, David Arthur Basketter, John Paul McFadden |
| 54 |
[GO] |
2020―May―05 |
Tocilizumab for cytokine storm syndrome in COVID-19 pneumonia: an increased risk for candidemia? |
Spinello Antinori, Cecilia Bonazzetti, Guido Gubertini, Amedeo Capetti, Cristina Pagani, Valentina Morena, Sara Rimoldi, Laura Galimberti, Piercarlo Sarzi-Puttini, Anna Lisa Ridolfo |
| 55 |
[GO] |
2020―May―05 |
Convalescent plasma in Covid-19: Possible mechanisms of action |
Manuel Rojas, Yhojan Rodriguez, Diana M. Monsalve, Yeny Acosta-Ampudia, Bernardo Camacho, Juan Esteban Gallo, Adriana Rojas-Villarraga, Carolina Ramírez-Santana, Juan C. Díaz-Coronado, Rubén Manrique, Ruben D. Mantilla, Yehuda Shoenfeld, Juan-Manuel Anaya |
| 56 |
[GO] |
2020―May―05 |
SARS-CoV-2 infection among patients with systemic autoimmune diseases |
Giacomo Emmi, Alessandra Bettiol, Irene Mattioli, Elena Silvestri, Gerardo Di Scala, Maria Letizia Urban, Augusto Vaglio, Domenico Prisco |
| 57 |
[GO] |
2020―May―05 |
Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis |
Omer Gendelman, Howard Amital, Nicola Luigi Bragazzi, Abdulla Watad, Gabriel Chodick |
| 58 |
[GO] |
2020―May―04 |
Imatinib might constitute a treatment option for lung involvement in COVID-19 |
David Bernal-Bello, Beatriz Jaenes-Barrios, Alejandro Morales-Ortega, José Manuel Ruiz-Giardin, Virginia García-Bermúdez, Begoña Frutos-Pérez, Ana Isabel Farfán-Sedano, Cristina de Ancos-Aracil, Fernando Bermejo, Mario García-Gil, Antonio Zapatero-Gaviria, Juan Víctor San Martín-López |
| 59 |
[GO] |
2020―May―04 |
Cytokine storm syndrome in severe COVID-19 |
Piero Ruscitti, Onorina Berardicurti, Annamaria Iagnocco, Roberto Giacomelli |
| 60 |
[GO] |
2020―May―04 |
Immunomodulatory therapy for the management of severe COVID-19. Beyond the anti-viral therapy: A comprehensive review |
Jaume Alijotas-Reig, Enrique Esteve-Valverde, Cristina Belizna, Albert Selva-O'Callaghan, Josep Pardos-Gea, Angela Quintana, Arsene Mekinian, Ariadna Anunciacion-Lunell, Francesc Miró-Mur |
| 61 |
[GO] |
2020―May―04 |
Seven recommendations to rescue the patients and reduce the mortality from COVID-19 infection: An immunological point of view |
Andreas Kronbichler, Maria Effenberger, Michael Eisenhut, Keum Hwa Lee, Jae Il Shin |
| 62 |
[GO] |
2020―May―04 |
Tocilizumab for the treatment of severe COVID-19 pneumonia with hyperinflammatory syndrome and acute respiratory failure: A single center study of 100 patients in Brescia, Italy |
Paola Toniati, Simone Piva, Marco Cattalini, Emirena Garrafa, Francesca Regola, Francesco Castelli, Franco Franceschini, Emanuele Focà, Laura Andreoli, Nicola Latronico |
| 63 |
[GO] |
2020―May―04 |
Interleukin-17A (IL-17A), a key molecule of innate and adaptive immunity, and its potential involvement in COVID-19-related thrombotic and vascular mechanisms |
Federica Raucci, Adel Abo Mansour, Gian Marco Casillo, Anella Saviano, Francesco Caso, Raffaele Scarpa, Nicola Mascolo, Asif Jilani Iqbal, Francesco Maione |
| 64 |
[GO] |
2020―May―04 |
Should we stimulate or suppress immune responses in COVID-19? Cytokine and anti-cytokine interventions |
Yvan Jamilloux, Thomas Henry, Alexandre Belot, Sébastien Viel, Maxime Fauter, Thomas El Jammal, Thierry Walzer, Bruno François, Pascal Sève |
| 65 |
[GO] |
2020―May―03 |
Fatal COVID-19 infections: Is NK cell dysfunction a link with autoimmune HLH? |
Mohammed S. Osman, Charmaine van Eeden, Jan Willem Cohen Tervaert |
| 66 |
[GO] |
2020―May―03 |
Transcriptional landscape of SARS-CoV-2 infection dismantles pathogenic pathways activated by the virus, proposes unique sex-specific differences and predicts tailored therapeutic strategies |
Paolo Fagone, Rosella Ciurleo, Salvo Danilo Lombardo, Carmelo Iacobello, Concetta Ilenia Palermo, Yehuda Shoenfeld, Klaus Bendtzen, Placido Bramanti, Ferdinando Nicoletti |
| 67 |
[GO] |
2020―May―01 |
Re: Patiently waiting for the results of anti-IL 6 therapy in severe COVID-19 infection |
Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood |
| 68 |
[GO] |
2020―May―01 |
Molecular mimicry between SARS-CoV-2 and respiratory pacemaker neurons |
Guglielmo Lucchese, Agnes Flöel |
| 69 |
[GO] |
2020―May―01 |
The correlation between SARS-CoV-2 infection and rheumatic disease |
Zhao-wei Gao, Xi Wang, Fang Lin, Ke Dong |
| 70 |
[GO] |
2020―May―01 |
SARS-CoV-2 infection complicated by inflammatory syndrome. Could high-dose human immunoglobulin for intravenous use (IVIG) be beneficial? |
Marcella Prete, Elvira Favoino, Giacomo Catacchio, Vito Racanelli, Federico Perosa |
| 71 |
[GO] |
2020―Apr―05 |
Corona (COVID-19) time musings: Our involvement in COVID-19 pathogenesis, diagnosis, treatment and vaccine planning |
Yehuda Shoenfeld |
| 72 |
[GO] |
2020―Apr―04 |
ACE2 at the centre of COVID-19 from paucisymptomatic infections to severe pneumonia |
Felice Rivellese, Edoardo Prediletto |
| 73 |
[GO] |
2020―Apr―04 |
The Role of Cytokines including Interleukin-6 in COVID-19 induced Pneumonia and Macrophage Activation Syndrome-Like Disease |
Dennis McGonagle, Kassem Sharif, Anthony O'Regan, Charlie Bridgewood |
| 74 |
[GO] |
2020―Apr―03 |
What is the role of rheumatologists in the era of COVID-19? |
Daniela Marotto, Piercarlo Sarzi-Puttini |
| 75 |
[GO] |
2020―Mar―20 |
COVID-19 infection and rheumatoid arthritis: Faraway, so close! |
Ennio Giulio Favalli, Francesca Ingegnoli, Orazio De Lucia, Gilberto Cincinelli, Rolando Cimaz, Roberto Caporali |
|
